259 related articles for article (PubMed ID: 24313769)
1. Significance of the microbiome in chronic obstructive pulmonary disease.
Martinez FJ; Erb-Downward JR; Huffnagle GB
Ann Am Thorac Soc; 2013 Dec; 10 Suppl(Suppl):S170-9. PubMed ID: 24313769
[TBL] [Abstract][Full Text] [Related]
2. The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives.
Dima E; Kyriakoudi A; Kaponi M; Vasileiadis I; Stamou P; Koutsoukou A; Koulouris NG; Rovina N
Respir Med; 2019 Oct; 157():1-6. PubMed ID: 31450162
[TBL] [Abstract][Full Text] [Related]
3. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
[TBL] [Abstract][Full Text] [Related]
4. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
Wu Y; Luo Z; Liu C
Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
[TBL] [Abstract][Full Text] [Related]
5. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.
Leung JM; Tiew PY; Mac Aogáin M; Budden KF; Yong VF; Thomas SS; Pethe K; Hansbro PM; Chotirmall SH
Respirology; 2017 May; 22(4):634-650. PubMed ID: 28342288
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
[TBL] [Abstract][Full Text] [Related]
7. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
8. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
Lee SW; Kuan CS; Wu LS; Weng JT
PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?
Sethi S
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S43-7. PubMed ID: 24437405
[TBL] [Abstract][Full Text] [Related]
10. COPD and the microbiome.
Mammen MJ; Sethi S
Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
[TBL] [Abstract][Full Text] [Related]
11. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
[TBL] [Abstract][Full Text] [Related]
12. Sputum microbiome profiling in COPD: beyond singular pathogen detection.
Ditz B; Christenson S; Rossen J; Brightling C; Kerstjens HAM; van den Berge M; Faiz A
Thorax; 2020 Apr; 75(4):338-344. PubMed ID: 31996401
[TBL] [Abstract][Full Text] [Related]
13. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
[TBL] [Abstract][Full Text] [Related]
14. Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease.
D'Anna SE; Maniscalco M; Cappello F; Carone M; Motta A; Balbi B; Ricciardolo FLM; Caramori G; Stefano AD
Ann Med; 2021 Dec; 53(1):135-150. PubMed ID: 32997525
[TBL] [Abstract][Full Text] [Related]
15. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
[TBL] [Abstract][Full Text] [Related]
16. Murine model of chronic respiratory inflammation.
Lugade AA; Bogner PN; Thanavala Y
Adv Exp Med Biol; 2011; 780():125-41. PubMed ID: 21842370
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammation and the effects of short-term antibiotic treatment for PPM positive patients with stable COPD.
Wang JX; Li HQ; Zhang F; Ning W
Int J Chron Obstruct Pulmon Dis; 2019; 14():1923-1932. PubMed ID: 31692553
[TBL] [Abstract][Full Text] [Related]
18. Saliva as a non-invasive specimen for COPD assessment.
Melo-Dias S; Valente C; Andrade L; Marques A; Sousa A
Respir Res; 2022 Jan; 23(1):16. PubMed ID: 35093093
[TBL] [Abstract][Full Text] [Related]
19. Analysis of microbiota in stable patients with chronic obstructive pulmonary disease.
Aguirre E; Galiana A; Mira A; Guardiola R; Sánchez-Guillén L; Garcia-Pachon E; Santibañez M; Royo G; Rodríguez JC
APMIS; 2015 May; 123(5):427-32. PubMed ID: 25858184
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB
PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
